Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia

Internal Medicine Journal

Volumn 45, Issue 1, 2015, Pages 86-93

  Xu, S ^a   Alexander, K ^b   Bryant, W ^c   Cohen, N ^c   Craig, M E ^d,e   Forbes, M ^f   Fulcher, G ^b   Greenaway, T ^g   Harrison, N ^h   Holmes Walker, D J ⁱ   Howard, G ^j   Jackson, J ^k   Jenkins, A ^l   Kamp, M ^m   Kaye, J ^n,o   Sinha, A ^p   Stranks, S ^q   O'Neal, D ^l   Colman, P ^r  

^a ST VINCENT S HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e Geelong Endocrinology and Diabetes   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

^g ST VINCENT S HOSPITAL   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^j WESTMEAD HOSPITAL   (Australia)

^k Manly Consulting Suite ^*  (Australia)

^l GOLD COAST HOSPITAL AND HEALTH SERVICE   (Australia)

^m METRO NORTH HOSPITAL AND HEALTH SERVICE   (Australia)

ⁿ Queensland Department of Health   (Australia)

^o ROYAL HOBART HOSPITAL   (Australia)

^p Oxford Close Specialist Centre   (Australia)

^q SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^r REPATRIATION GENERAL HOSPITAL   (Australia)

more..

Author keywords

Health resource; Health service need and demand; Insulin; Insulin infusion system; Type 1 diabetes mellitus

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ADULT; ARTICLE; AUSTRALIA; DIABETES MELLITUS; DIABETIC PATIENT; DIETITIAN; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; NURSE; PATIENT CARE; PRIORITY JOURNAL; RESOURCE MANAGEMENT; ADOLESCENT; AGED; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; HUMAN RELATION; INSULIN INFUSION; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; PROSPECTIVE STUDY; STANDARDS; TRENDS; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH PERSONNEL; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; MORBIDITY; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL-PATIENT RELATIONS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84920986736     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12619     Document Type: Article

References (18)

1. Pickup J. Insulin pumps. Int J Clin Pract Suppl 2011; 170: 16-19.
2. Australian Institute of Health and Welfare. Insulin pump use in Australia. Diabetes series no. 18. Cat. no. CVD 58. Canberra: AIHW; 2012.
3. Gallen I, Bilous R, Campbell F, Amiel S, Hammond P, Jordan L etal. The United Kingdom Insulin Pump Audit; 2013.
4. Pickup JC, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with Type 1 Diabetes: meta-analysis of Random Controlled Trials. BMJ 2002; 324: 705-710.
5. Craig M, Twigg S, Donaghue K, Cheung N, Cameron F, Conn J etal. National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults. Canberra: Australian Government Department of Health and Ageing; 2011.
6. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996; 19: 324-327.
7. Hoogma RPLM, Hammond PJ, Gomist R, Kerr D, Bruttomesso D, Bouter KP etal. Comparison of the effects of CSII and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med 2005; 23: 141-147.
8. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003; 26: 1079-1087.
9. Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia 2013; 56: 2392-2400.
10. Institute of Health Economics. Insulin Pump Therapy for Type 1 Diabetes. Edmonton: IHE; 2012.
11. Scuffham P, Carr L. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes. Diabet Med 2003; 20: 586-593.
12. Roze S, Valentine W, Zakrzewska K, Palmer A. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK. Diabet Med 2005; 22: 1239-1245.
13. National Institute for Health and Clinical Excellence. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. London: NICE; 2008. NICE technology appraisal guidance 151 (Review of technology appraisal guidance 57).
14. Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L etal. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 2010; 14: 1-181.
15. Somerville R. The Economic Benefit of the Funding of Insulin Pumps in Alberta. Canadian Diabetes Association; 2011.
16. Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia. Pharmacoeconomics 2007; 25: 881-897.
17. The Australian National Adult Insulin Pump Therapy Working Group. Provision of quality care for adults with Type 1 diabetes requiring insulin pump therapy (IPT). Infusystems Asia 2013; 8: 1-6.
18. Guilhem I, Balkau B, Lecordier F, Malécot J-M, Elbadii S, Leguerrier A-M etal. Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia 2009; 52: 2662-2664.